Prevention of diastolic heart failure by endothelin type A receptor antagonist through inhibition of ventricular structural remodeling in hypertensive heart. [electronic resource]
- Journal of hypertension Apr 2002
- 753-61 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0263-6352
10.1097/00004872-200204000-00035 doi
Animals Diastole Endothelin Receptor Antagonists Heart Failure--etiology Hemodynamics--drug effects Hypertension--complications Hypertrophy, Left Ventricular Male Pyrimidines--pharmacology Rats Rats, Inbred Dahl Receptor, Endothelin A Sulfonamides--pharmacology Ventricular Remodeling--drug effects